Medtronic Receives FDA Approval for Neurostimulator; Shares Rise 1.4%
Shares of Medtronic (MDT) gained 1.4% after the company received approval from the U.S. Food and Drug Administration for Vanta, a recharge-free implantable neurostimulator.
The neurostimulator offers personalized pain relief, broad MRI compatibility, and…
